Synergistic toxicity between tau and amyloid drives neuronal dysfunction and neurodegeneration in transgenic C. elegans
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic toxicity between tau and amyloid drives neuronal dysfunction and neurodegeneration in transgenic C. elegans
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 29, Issue 3, Pages 495-505
Publisher
Oxford University Press (OUP)
Online
2019-12-31
DOI
10.1093/hmg/ddz319
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tau tubulin kinases in proteinopathy
- (2019) Laura M. Taylor et al. FEBS Journal
- Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation
- (2019) Takashi Saito et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Traumatic brain injury induces tau aggregation and spreading
- (2019) George A Edwards III et al. JOURNAL OF NEUROTRAUMA
- DOPA Decarboxylase Modulates Tau Toxicity
- (2018) Rebecca L. Kow et al. BIOLOGICAL PSYCHIATRY
- Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans
- (2018) Chenyin Wang et al. NEUROBIOLOGY OF DISEASE
- The neurobiological effects of repetitive head impacts in collision sports
- (2018) Liane E. Hunter et al. NEUROBIOLOGY OF DISEASE
- Alzheimer's disease
- (2017) C. A. Lane et al. EUROPEAN JOURNAL OF NEUROLOGY
- Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015
- (2017) Dev Mehta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Why do so many clinical trials of therapies for Alzheimer's disease fail?
- (2017) Roy M Anderson et al. LANCET
- Merck ends trial of potential Alzheimer’s drug verubecestat
- (2017) Nigel Hawkes BMJ-British Medical Journal
- Merck ends trial of potential Alzheimer’s drug verubecestat
- (2017) Nigel Hawkes BMJ-British Medical Journal
- Why has therapy development for dementia failed in the last two decades?
- (2016) Serge Gauthier et al. Alzheimers & Dementia
- Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease
- (2016) Rosemary J. Jackson et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- MSUT2 is a determinant of susceptibility to tau neurotoxicity
- (2011) Chris R. Guthrie et al. HUMAN MOLECULAR GENETICS
- AGS-3 Alters Caenorhabditis elegans Behavior after Food Deprivation via RIC-8 Activation of the Neural G Protein G o
- (2011) C. Hofler et al. JOURNAL OF NEUROSCIENCE
- Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1
- (2011) Bettina Platt et al. PLoS One
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans
- (2009) Chris R. Guthrie et al. HUMAN MOLECULAR GENETICS
- Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice
- (2009) Fiona Grueninger et al. NEUROBIOLOGY OF DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now